Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(29)
- Computing and Computational Sciences Directorate (39)
- Energy Science and Technology Directorate (229)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (138)
- User Facilities (28)
Researcher
- Ryan Dehoff
- Brian Post
- Michael Kirka
- Venkatakrishnan Singanallur Vaidyanathan
- Vincent Paquit
- Adam Stevens
- Ahmed Hassen
- Alex Plotkowski
- Alex Roschli
- Alice Perrin
- Amir K Ziabari
- Amit Shyam
- Andres Marquez Rossy
- Blane Fillingim
- Brian Sanders
- Cameron Adkins
- Christopher Ledford
- Clay Leach
- David Nuttall
- Diana E Hun
- Gerald Tuskan
- Gina Accawi
- Gurneesh Jatana
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Isha Bhandari
- James Haley
- Jeff Foster
- Jerry Parks
- John F Cahill
- Josh Michener
- Liam White
- Liangyu Qian
- Mark M Root
- Michael Borish
- Patxi Fernandez-Zelaia
- Paul Abraham
- Peeyush Nandwana
- Philip Bingham
- Philip Boudreaux
- Rangasayee Kannan
- Roger G Miller
- Sarah Graham
- Sudarsanam Babu
- Vilmos Kertesz
- Vipin Kumar
- Vlastimil Kunc
- William Peter
- Xiaohan Yang
- Yan-Ru Lin
- Yang Liu
- Ying Yang
- Yukinori Yamamoto

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

We have been working to adapt background oriented schlieren (BOS) imaging to directly visualize building leakage, which is fast and easy.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

High strength, oxidation resistant refractory alloys are difficult to fabricate for commercial use in extreme environments.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

In manufacturing parts for industry using traditional molds and dies, about 70 percent to 80 percent of the time it takes to create a part is a result of a relatively slow cooling process.

This technology combines 3D printing and compression molding to produce high-strength, low-porosity composite articles.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).